Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
It is administered via weekly injections and contains a GLP-1 receptor that helps to curb appetite
Nicknamed the 'Godzilla' or the 'final boss' of weight-loss drugs, Retatrutide is an injectable 'triple G' agonist medicine that targets GLP-1, GIP, and glucagon in the body, suppressing appetite and slowing digestion
References: National Center for Biotechnology Information.
[7] Alzheimer's disease Alzheimers disease is a neurodegenerative dementia that appears to be caused by accumulations of beta amyloid plaques, as well as changes in how the brain metabolizes glucose
Retatrutide is a groundbreaking triple-agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors
US$ 24.91
US$ 28.29
US$ 23.30
US$ 20.41
